Planned:

National and International:

Present-2000

• SUO 23rd Annual Meeting, “Targeting VPAC in voided urine for detecting prostate cancer.” San Diego, CA, November 29 – December 2, 2022.

• 14^th Annual WARMTH Conference, Nanjing, China. “WARMTH 2019, Ajit Padhy Oration” August 2019.

• SNMMI Annual Meeting, Philadelphia, PA. “PET imaging of urothelial bladder cancer: addressing an unmet need”, and “Comparison of N₂S₂ and NODAGA as chelators for ⁶⁴Cu-labeled PET imaging in mice bearing prostate tumor”. Philadelphia, PA, June 2019.

• ISORBE & Israel Society of Nuclear Medicine, Neve Ilan Hotel, Tel Aviv, Israel. “Stem cells; A regenerative pharmaceutical”, March 8, 2019.

• SNMMI Annual Meeting, Philadelphia, PA. “Currently Available Radiopharmaceuticals”, “Diagnostic Approaches to Urological Oncology”, “VPAC1 biomarker for imaging triple negative breast cancer”, “A comparison of in vivo stability of Ga-68 labeled peptide conjugate for targeting VPAC receptors”. Philadelphia, PA, June 2018.

• 49th Annual Conference of the Society of Nuclear Medicine, “VPAC1 for Diagnosis and Treatment of Clinical Pathologies”. New Delhi, India, December 2017.

• 13th International Symposium on VIP, PACAP and Related Peptides, “VPAC Platform in the Theranostic Oncology”. Hong Kong, December 2017.

• 18th Annual Meeting of Society of Urologic Oncology Plenary, “VPAC1: A Novel Target for Imaging Prostate Cancer”. Washington, DC, November 2017.

• 12th WARMTH Congress ICRT, “Cu-64/Cu-67 Theranostics for Urothelial Malignancies”, Vienna, Austria. October 2017.

• 10^th Annual World Cancer Congress, “Translating Comprehensive Molecular Approach to Oncologic Diagnosis in Humans”. Barcelona, Spain, May 2017.

• Thomas Jefferson University President’s Mission. Summary of Ongoing Projects on Diagnostic Imaging. Belgaum, India, November 2016.

• International Conference on Radiation Biology. Chennai, India, 2016

• 2nd World Congress on Cancer. Singapore, 2016

• American Chemical Society Annual Meeting, Philadelphia, PA, 2016.

• 47^th Annual Conference of SNM India. Puducherry, November 2015.

• Biofluids and High – Value Diagnostics. Boston, September 2015.

• World Congress on Cancer and Prevention Methods. Dubai, August 2015

• Annual Congress of International Isotope Society. Novel emerging technologies in PET imaging of breast and prostate cancer, plenary presentation. Princeton, NJ June 2015.

• Seventeenth ISORBE Congress. Optical imaging of infection; Stem cells. Izmir, Turkey. March 2015.

• American Nuclear Society Eighth International Conference on Isotopes. Chicago, IL. August 2014.

• Seventy – second Annual Meeting. Vasoactive intestinal peptide and pituitary adenylate cyclase activation peptide receptor 1 (VPAC1) targeted detection of genitourinary cancer: A urinary assay. Baltimore, MD. September 2014.

• Eleventh Congress of World Federation of Nuclear Medicine and Biology on Infection and Inflammation Imaging. Round table, interactive session. Cancun, Mexico. Aug 2014.

• Eleventh Congress of World Federation of Nuclear Medicine and Biology on Exploiting Genomic Biomarkers for Diagnosis and Therapy. Invited Plenary Presentation. Cancun, Mexico. Aug 2014.

• Eleventh Congress of World Federation of Nuclear Medicine and Biology on New Developments in Radiolabeled Cells. Invited Plenary Presentation. Cancun, Mexico. Aug 2014.

• Sixty Ninth Annual Meeting of the SNMMI, St. Louis MO “Imaging bladder cancer: Correlation with histopathologic findings” June 5 – 11, 2014.

• NuView, Incorporated, Philadelphia, PA “Targeting VPAC1 receptors an update” Invited Presentation. April 24, 2014.

• International Congress on Radiation Medicine, Riyadh, Saudi Arabia “Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA” “Innovations in PET breast cancer imaging techniques” Invited Presentation. February 15 – 21, 2014.

• Indian Science Congress Association, Jammu, India “Targeted genomic biomolecules for diagnosis and therapy: From basic research to clinical perspective” Invited Presentation. February 8, 2014.

• 3rd International Conference on Applications of Radiotracers and Energetic Beams in Science, Kolkata, India “Radiolabeled biomarkers for specific imaging of the cancers of the breast, prostate and lungs” Invited Presentation. January 9 – 14, 2014.

• Role of Lipid soluble Complexes in Targeted Therapy. International Conference on Radiation Medicine, Riyadh, Saudi Arabia, 2014.

• Determining Efficacy of Breast Cancer Therapy by PET Imaging of HER2 mRNA. International Conference on Radiation Medicine, Riyadh, Saudi Arabia, 2014.

• Genetic Approaches to PET Imaging of Breast Cancer: Why do we need this approach? International Conference on Radiation Medicine, Riyadh, Saudi Arabia, 2014.

• Targeted Genomic Biomarkers for Diagnosis and Therapy from Basic Research to Clinical Perspective. Indian Science Congress Association, Jammu, India, 2014.

• Radiolabeled Biomolecular for the Specific Imaging of Cancers of the Breast, Prostate and Lungs. Third International Conference on Applications of Radiotracers and Energetic Beams in Science, Kolkata, India, 2014.

• Sixty Eighth Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, Vancouver, Canada “Remembering Henry Wagner, Jr." Invited Presentation. June 8 – 12, 2013

• University City Science Center, Philadelphia PA “Imaging genomic biomarkers for diagnosis and therapy" Invited Presentation. May 22, 2013

• 11th International Symposium on VIP, PACAP and Related Peptides, Pecs Hungary “PET imaging of KRAS2 activated lung cancer in transgenic mice using VPAC1 receptor specific for Cu – 64 – TP3805” “Personalized examination of VPAC1 biomarkers for detecting genitourinary cancer” Invited Presentation. Aug 25 – Sept 23, 2013.

• Annual Congress of European Association of Nuclear Medicine, Lyon, France “Detecting genitourinary Cancer ex vivo: “Correlation with histopathologic findings” October 16 – 25, 2013.

• 14th International Conference of International Society of Radiolabeled Blood Elements (ISORBE), Pretoria, South Africa “Stem cells; a regenerative pharmaceutical “Highlights of the 14th International Conference of International Society of Radiolabeled Blood Elements (ISORBE)" Invited Presentation. March 19 – 27, 2013

• Bruckner, Inc. training course at Princeton University, Princeton, NJ “Molecular imaging: from bench to bedside" Invited Presentation. March 11, 2013

• 2nd World Congress on Medical Applications of Ga – 68, Chandigarh, India “Can Ga – 68 contribute to the welfare of women suspected to have breast cancer?" Invited Presentation. February 27 – March 13, 2013

• ImaginAb, Inc., Los Angeles, CA “Targeting CD 15 receptors for imaging infection" Invited Presentation. November 8, 2012

• Department of Pathology, Yale University, New Haven, CT “Molecular imaging: from bench to bedside" Invited Presentation. November 1, 2012

• National Institute of Health, Bethesda, MD “Radiolabeled blood cells: imaging infection" Invited Presentation. September 27, 2012

• United Pharmacy Partners, Inc. Philadelphia, PA “Targeting genomic biomarkers for oncologic imaging" Invited Presentation. September 15, 2012

• NuView, Inc. Salt Lake City, UT “Targeting VPAC1 genomic biomarkers for PET/PEM imaging of breast cancer" Invited Presentation. August 27 – 29, 2012

• Society of Radiolabeled Blood elements, “Dual Tracer, Optical and radionuclide Imaging of Infection” Invited Presentation. 2011

• NIH/SNM workshop on Infection Imaging, “Targeting Apoptosis for Optical Imaging of Infection” Invited Presentation. Bethesda, 2011

• 42nd Annual Meeting of SNM – India. “Genetic PET imaging in translational research” Chandigarh, India. Invited Presentation. 2010

• Indo – US workshop on, “Targeting biomarkers for diagnosis and therapy”, “Applications of molecular imaging in health and disease and drug discovery” Hyderabad, India. Invited Presentation. November, 2010

• “Targeting genomic biomarkers in molecular imaging” WFNMB Cape Town, South Africa. Plenary presentation. 2010

• “Imaging gene expression” WFNMB, Cape Town, South Africa. Plenary presentation. 2010

• “Molecular imaging” WFNMB, Cape Town, South Africa. A lunchtime seminar. 2010

• “Role of molecular imaging in diagnosis and therapy” Johns Hopkins University, Baltimore MD. Invited Presentation. December 9, 2010

• Bogota Medical Center, University of Bogota, Colombia. “Targeting genomic biomarkers for imaging breast cancer” Invited Presentation. November 8, 2010

• 23rd Annual Meeting of the Association of Latin of Nuclear medicine. Cartagena, Colombia. “Role of high sensitivity – high resolution micro PET in molecular imaging. “Future directions in imaging infection” Invited Presentation. November 6 – 7, 2010

• 30th Annual Meeting of the European Association of nuclear medicine, Barcelona, Spain. “Imaging infection – challenges and prospects” Plenary presentation. October 12, 2010

• 18th International Symposium in Radiopharmaceutical Sciences, Edmonton, Canada. “VPAC1 gene product targeted PET imaging of breast cancer” July 14, 2010

• “Targeting Genomic Biomarker for Imaging Breast Cancer” 18th Annual Meeting of ALASBIMN, Cartagena, Colombia. November 3 – 7, 2009

• “Imaging Infection: Challenges and Prospects” 36th Annual Meeting of EANM. Barcelona, Spain. October 10 – 14, 2009

• Soc. Nucl. Med. 56th Annual meeting Toronto, Canada “PET imaging of spontaneous mouse mammary tumor virus (MMTV) infected breast cancer (BC) using Cu – 64 – TP3805”. June 11 – 17, 2009

• AAPM, Spring Symposium Philadelphia, PA “Molecular Imaging of Breast Cancer”. April 24, 2009

• Int. Symposium Molecular Imaging & Therapy Road Map to Modern Medicine Kuwait University “Therapeutic Radiopharmaceuticals”. March 11, 2009

• Int. Symposium Molecular Imaging & Therapy Road Map to Modern Medicine, Kuwait University “Genomic biomarkers for Molecular Imaging”. March 9, 2009

• University Of Pennsylvania “Mechanism of Radiopharmaceutical uptake”. March 4, 2009

• Trace Life Sciences, Dallas TX “Cu – 64 – biomolecules for diagnosis and Therapy”. Dec. 11, 2008

• 9th Asia, Oceania Congress of Nucl. Med. Biol. New Delhi, India “PNA based Radiopharmaceuticals for Targeted Therapy” “Imaging Infection and Inflammation” “Radionuclides in Therapy. Critical Evaluation”. Oct. 31 – Nov. 4, 2008

• International Symposium on Radiopharmaceutical Therapy, Goa, India “Lipid soluble radioactive agents for Intratumoral therapy” “Approaches to Stem Cell Therapy” Oct. 27 – 30, 2008

• “Genomic Biomarkers for Molecular Imaging: Predicting the Future” 55th Annual Meeting of the Board of Nuclear Medicine. New Orleans, Louisiana. June 15 – 18, 2008

• “Stem Cells: A Regenerative Pharmaceutical” Nuclear Medicine Tomorrow. Nantes, France March 30 – April 12, 2008

• “Radiopharmaceuticals for Targeted Therapy” 6th International Conference on Isotopes. Seoul, South Korea May 12 – 16, 2007

• “Future Trends in Molecular Imaging” 39th Annual Meeting of Society of Nuclear Medicine India. Lucknow, India December 6 – 9,2007

• “Stem Cells” 13th Symposium of International Society of Radiolabeled Blood Elements. Santa Cruz, Bolivia December 1, 2007

• “Trends in Radiopharmaceutical development and use” and “Molecular Imaging. Future Directions” 21st ALASBIMN Annual Meeting. Santa Cruz, Bolivia December 1 – 4, 2007

• “PET Imaging of Prostate Cancer: A New Approach to an Old Problem” and “PET targeting of Breast Cancer; Role of Receptor Specific Peptides” 20th Annual meeting of Eur. Association. Copenhagen, Denmark October 13 – 17, 2007

• “Molecular Approach to PET Imaging of Prostate Cancer” AdMeTech Foundation Washington D.C. September 17, 2007

• “Radiolabeling Biomolecules for Molecular Imaging: Theory and Applications” Johnson & Johnson Centocor, Pennsylvania August 15, 2007

• “Copper – 64 – Breast and Prostate Diagnostics” NuView Radiopharmaceuticals Inc. Park City, Utah July 27,2007

• “Molecular Imaging: Shaping the future” and “PET imaging of Hormone Dependent Cancers” MDs Nordion Inc. Toronto, Canada July 2, 2007

• International Atomic Energy Agency, Vienna, 2007

• International Atomic Energy Agency, Vienna, 2006

• WFNMB, Seoul Korea. Invited Presentation. 2006

• “Approach to Imaging Oncogene Expression”, “Annual Lecture” 34 Annual Meeting of the British Nuclear Medicine Society. Manchester, England. Invited Presentation. March 28, 2006

• “Applications of Radiotracers in Biological Sciences” International Conference in Applications of Radiotracers in Chemical, Environmental and Biological Sciences. Saha Institute of Nuclear Physics. Kolkata, India. Invited Presentation. January 26, 2006

• International, Atomic Energy Agency, Vienna, 2005

• Japanese Soc. of Nucl Med, Kagoshima. Plenary Presentation. 2005

• British Soc. Nucl. Med; Manchester. Plenary Presentation. 2005

• Senate Caucus, US Senate, 2005

• Society of Nuclear Medicine, 52nd Annual Meeting, Toronto, Canada “Cu – 64 labeled PNA for Imaging Pancreatic Cancer” NeutroSpec. Invited Presentation. June 16 – 23, 2005

• Society of Nuclear Medicine, Central Chapter, Annual Meeting Chicago, IL. ”Recent Advances in Radiopharmaceuticals” Invited Presentation. March 31 – April 1, 2005

• Society of Nuclear Medicine, Greater New York Chapter, Annual Meeting, “Imaging Infection: Now and the Future” Invited Presentation. April 30 – May 2, 2005

• American Association of Pharmacists, Annual Meeting, Orlando, FL. “Imaging Infection using NeutroSpec” Invited Presentation. April 2 – 3, 2005

• Eastern Isotopes Annual Gathering, Vallarta, Mexico. “Recent development of positron Radiopharmaceuticals” Invited Presentation. February 3 – 5, 2005

• “Society of Nuclear Medicine, Mid – winter Meeting, Tampa, FL. “Imaging Infection: NeutroSpec” Invited Presentation. January 26 – 30, 2005

• “Genomic approaches to Molecular Imaging” 20th Congress of Association of Latin American Societies of Biology and Nuclear Medicine. Invited Presentation. December 7, 2005.

• “Introduction to the Society of Radiolabeled Blood Elements” 20th Congress of Association of Latin American Societies of Biology and Nuclear Medicine. Invited Presentation. December 6, 2005.

• “New Trends in Radiopharmaceuticals for diagnosing infection/inflammation” 20th Congress of Association of Latin American Societies of Biology and Nuclear Medicine. Invited Presentation. December 6, 2005.

• “Pharmacology of radiolabeled Peptides” International Symposium in Trends in Radiopharmaceuticals. Atomic Energy Agency. Vienna, Austria. Invited Presentation. November 15, 2005

• “Opening Remarks” International Symposium in Trends in Radiopharmaceuticals. Atomic Energy Agency. Vienna, Austria. Invited Presentation. November 14, 2005.

• “Berson Yalow Award Presentation” Annual Meeting of GNY and NE Chapter of Society of Nuclear Medicine. Newport, RI. Invited Presentation. October 29, 2005.

• “Peptides in Oncology Imaging” Annual meeting of GNY and NE Chapter of Society of Nuclear Medicine. Newport, RI. Invited Presentation. October 28, 2005.

• “Role of Neutrophil Specific Antibodies in Imaging Infection” Annual Meeting of European Association of Nuclear Medicine. Istanbul, Turkey. Invited Presentation. October 18, 2005.

• “Imaging Oncogene mRNA” Meeting of the European Association of Nuclear Medicine. Istanbul, Turkey. Invited Presentation. October 18, 2005.

• “New Results” 12th meeting of the International Society of Radiolabeled Blood Elements. Villigen, Switzerland. Invited Presentation. September 2, 2005

• “Stem Cells. A Regenerative Pharmaceutical” Istanbul, Turkey. 12th meeting of the International Society of Radiolabeled blood Elements. Villigen, Switzerland. Invited Presentation. September 2, 2005

• American College of Nuclear medicine, Physicians Annual Meeting, San Diego, CA. “New Tracers for imaging infection (including FDG)” Invited Presentation. January 15 – 19, 2005.

• Chinese Soc. of Nucl. Med, Beijing. Invited Presentation. Plenary Presentation. 2005.

• Society of Nuclear Medicine, 52nd Annual Meeting, Toronto, Canada. Invited Presentation. June 2005.

• Society of Nuclear Medicine, Central Chapter, Annual Meeting, Chicago, IL. Invited Presentation. April 2005.

• Society of Nuclear Medicine, Greater New York Chapter, Annual Meeting, Tarrytown, NY. Invited Presentation. May 2005.

• Senate Caucus, Washington, DC. Invited Presentation. April 2005.

• American Association of Pharmacists, Annual Meeting, Orlando, FL. Invited Presentation. April 2005.

• American College of Nuclear Physicians, Las Vegas, NV. Invited Presentation. February 2005.

• Society of Nuclear Medicine, Mid – winter Meeting, Tampa, FL. Invited Presentation. January 2005.

• American College of Nuclear Medicine, Physicians Annual Meeting, San Diego, CA. Invited Presentation. January 2005.

• Society of Nuclear Medicine. India, 36th Annual Meeting, Mysore, India. “Novel Radiopharmaceuticals for Molecular Imaging” Invited Presentation. December 15 – 18, 2004.

• Society of Nuclear medicine. India, 36th Annual Meeting, Pre – congress, Bangalore India. “PET Imaging of Oncogene Expression” Invited Presentation. December 13, 2004

• Japanese Society of Nuclear Medicine, Annual Meeting, Kyoto, Japan. “Recent Advances in Molecular Imaging” Invited Presentation. October 31 – November 7, 2004

• Society of Nuclear Medicine. New England chapter, Annual Meeting. “Toward NeutroSpec” Invited Presentation. October 22 – 24, 2004.

• Asia Oceania Federation in Nuclear Medicine and Biology, Beijing, china. “PET Imaging of Oncogene over expression” Invited Presentation. October 9 – 13,2004

• International Congress on Radiopharmacy and Radiochemistry. Istanbul, Turkey. “New Trends in Radiopharmaceutical Chemistry and Molecular Imaging” Invited Presentation. September 25 – 27, 2004.

• Annual Meeting of the Society of Nuclear Medicine, Philadelphia, PA “PET imaging of VPAC1 oncogene overexpression with Cu – 64 – vasoactive intestinal peptide (VIP)”, “Reparation and evaluation of Tc – 99m – peptide – PNA – peptide chimeras for imaging of CCND1 mRNA expression in human breast cancer xenografts”, “Imaging experimental pulmonary embolism (PE) in swine using fibrin specific peptide Tc – 99m – TP850” June 19 – 23,2004

• Society of Nuclear Medicine Chapter Annual Meeting, St. Louis, MO “Novel radiopharmaceuticals in imaging infection” May 17 – 18, 2004.

• Society of Nuclear Medicine Chapter Annual Meeting, Pittsburg, PA “Targeting oncogene expression for imaging breast cancer” March 5, 2004.

• Society of Nuclear Medicine, India, 36th Annual Meeting, Mysore, India. Invited Presentation. December 2004.

• Society of Nuclear Medicine, India, 36th Annual Meeting, Pre – congress, Bangalore India. Invited Presentation. December 2004.

• Oakwood Hospital, Detroit, Michigan. Invited Presentation. November 2004.

• Japanese Society of Nuclear Medicine, Annual Meeting, Kyoto, Japan. Invited Presentation. November 2004.

• Society of Nuclear Medicine, New England Chapter, Annual Meeting. Invited Presentation. October 2004.

• Asia Oceania Federation in Nuclear Medicine and Biology, Beijing, China. Invited Presentation. October 2004.

• International Congress on Radiopharmacy and Radiochemistry. Istanbul, Turkey. Invited Presentation. September 2004.

• Society of Nuclear Medicine Chapter, Annual Meeting, Detroit, MI “Recent advances in imaging infection” November 7 – 8,2003.

• Annual Meeting of the Brazilian Society of Nuclear Medicine and AIASBNM “Imaging Infection: Now and the future”, “Nuclear medicine and molecular imaging” August 26 – 31, 2003.

• Annual meeting of European Association of Nuclear Medicine Amsterdam, the Netherlands “Tc – 99m – vasoactive intestinal peptide: Influence of N4 VS N2S chelation”, “Imaging r – chain fibrin to image fresh and aged venous thrombosis (VT) and pulmonary embolism (PE) in swine” August 22 – 25, 2003.

• Annual congress of International Society of Radiopharmaceutical Chemistry and Biology, Sydney, Australia “Preparation of Cu – 64 and Tc – 99m – N2S2 vasoactive intestinal peptide (VIP) for imaging gene expression”, “Imaging oncogene mRNA with Tc – 99m PNA – Peptide chimeras” August 7 – 16, 2003.

• Chair, 50th Anniversary Committee, Society of Nuclear Medicine.

• Annual Congress of the Latin American Society of Biology and Nuclear Medicine (ALASBIMN), Cancun, Mexico. Invited Presentation. May 2003.

• Annual Meeting, Turkish Society of Nuclear Medicine, Samsun, Turkey. Invited Presentation. May 2003.

• Round Table Coordinator, International Society of Radiolabeled Blood Elements, Coimbra, Portugal, April 2003.

• Session Chair, International Society of Radiolabeled Blood Elements, Coimbra, Portugal, April 2003.

• Member, International Science Committee, International Society of Radiolabeled Blood Elements, Coimbra, Portugal, April 2003.

• Annual Meeting, International Society of Radiolabeled Blood Elements, Coimbra, Portugal. Invited Presentation. April 2003.

• NIH/NCI Workshop, San Diego, CA. Invited Presentation. February 2003.

• International Society of Radiolabeled Blood Elements, WFNMB Post – Congress, Santiago, Chile. Invited Presentation. October 2002.

• Member, Scientific Program Committee, World Federation of Nuclear Medicine and Biology, Santiago, Chile, October 2002.

• 8th World Federation of Nuclear Medicine and Biology, Santiago, Chile. Invited Presentation. October 2002.

• Session Chair, Continuing Medical Education, World Federation of Nuclear Medicine and Biology, Santiago, Chile, October 2002.

• Organizer, Continuing Medical Education, World Federation of Nuclear Medicine and Biology, Santiago, Chile, October 2002.

• Session chair, 1st International Meeting in Nuclear Medicine and Biology, Cabo Frio, Brazil, September 2002.

• 1st International Meeting in Nuclear Medicine and Biology, Cabo Frio, Brazil. Invited Presentation. September 2002.

• European Association of Nuclear Medicine Pre – Congress Meeting, Vienna, Austria. Invited Presentation. August 2002.

• 49th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, CA. June 2002.

• XXXVI Annual Congress of Nuclear Medicine, Leon, Mexico. May 2002.

• Kuwait Institute for Medical Specialization, Kuwait. March 2002.

• First Hospital of Beijing University, Beijing, China. December 2001.

• China Atomic Energy Agency, Beijing, China. December 2001.

• Imaging in 2020, Second Annual Workshop, Jackson Hole, WY. September 2001.

• Annual Meeting of the European Association of Nuclear Medicine Post – Congress, Capri, Italy. September 2001.

• 48th Annual Meeting of the Society of Nuclear Medicine, Toronto, Canada. June 2001.

• 10th Symposium of the International Society of Radiolabeled Blood Elements, Toronto, Canada. June 2001.

• 14th International Symposium on Radiopharmaceutical Chemistry, Interlaken, Switzerland. June 2001.

• 221st American Chemical Society Spring National Meeting, San Diego. April 2001.

• International Chem. Conference of Pacific Basin Societies. Hawaii. December 2000.

• SNM Greater New York/New England Chapter meeting, Providence, RI. November 2000.

• 7th Annual Meeting of the Asia and Oceania Congress of Nuclear Medicine and Biology, Istanbul, Turkey. October 2000.

• Pre – congress meeting of the 7th Meeting of the Asia and Oceania Congress of Nuclear Medicine and Biology, Istanbul, Turkey. October 2000.

• Annual Meeting of the European Society of Nuclear Medicine, Bordeaux, France. September 2000.

• The Rome 2000 Jubilee Symposium on Radiopharmaceuticals in Diagnosis and Therapy. May 2000.

• The Mid Eastern Chapter of the Society of Nuclear Medicine 30th Annual Spring Meeting. April 2000.

Commercial:

Present-2000

• NuView, Incorporated, Philadelphia, PA “Targeting VPAC1 receptors an update” Invited Presentation. April 24, 2014.

• Zevacor, International Isotopes, Forsyth, IL “Recent Advances in Molecular Imaging” Invited Presentation. October 6 – 8, 2013.

• Zevacor Molecular, Il, 2013

• 14th International Conference of International Society of Radiolabeled Blood Elements (ISORBE), Pretoria, South Africa, 2013

• Bruckner, Inc., Princeton, 2013

• ImaginAb, Inc., Los Angeles, 2012

• United Pharmacy Partners, Inc. Philadelphia, 2012

• NuView, Inc. Salt Lake City, 2012

• Carestream Healthcare, WFNMB, Cape Town 2010

• Siemens – ALASBIMN, Cartagena Colombia, 2009

• Johnson & Johnson – Pennsylvania, 2007

• NuView Radiopharmaceuticals, Utah, 2007

• Nordion – Canada, 2007

• IBA Molecular Belgium 2006

• IBA Molecular Belgium 2006

• Eastern Isotopes, 2005

• Amersham, 2004

• IBIS, France 2004

• Diatide, 2002

• G.E. Inc, 2001

• Diatide, Inc., 2000

• Palatin Technologies, Inc., 2000

• Bracco, Inc, 2000

University:

Present-2000

• Ruijin Hospital, Shanghai, China. “Diagnostic Approaches to Urologic Oncology”, August 20, 2019.

• KLE University, Dr. Prabhakar Kore Hospital. Belgaum, India. “Urinary Biomarkers for prostate cancer diagnosis”, March 16, 2019.

• KLE University, Dr. Prabhakar Kore Hospital. Belgaum, India. “Blood and serum biomarkers for diagnosis of prostate cancer”, March 16, 2019.

• Shah Institute of Nuclear Sciences, Kolkata, India. “Recent advance in oncologic diagnosis using Copper64”. December 21, 2018.

• University of Florida, Gainesville, FL, “Embracing Diversity for Excellence in Science” Invited Keynote Speaker. October 31, 2018.

• Abdulaziz University, Jeddah, Saudi Arabia, “Molecular imaging: From bench to bedside” Invited Presentation. February 14 – 15, 2014.

• Drexel University, Philadelphia, PA, “Genomic approaches to imaging concerns of the breast and prostate” Invited Presentation. June 30, 2014.

• Yale University School of Medicine. New Haven CT, 2012.

• Oklahoma University of Health Sciences, Lloyd Harris Distinguished Lecture “Exploiting Genomic Biomarkers for Oncologic imaging and Therapy” 2011.

• SNM/NIH, Breast Cancer Imaging Workshop. Bethesda MD, April 2011.

• SNM Annual Meeting, San Antonio, TX, June 2011.

• University of Colombia. Bogota, 2009.

• Juntendo University, Japan. Keynote speaker. 2006.

• The University of Texas, 2005.

• Oakwood Hospital, Detroit, Michigan, 2004.

• Kuwait Institute for Medical Specialization, 2002.

• First Hospital of Beijing University, 2001.

• China Atomic Energy Agency, 2001.

• University of Pennsylvania, 2000.